These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25016943)

  • 1. [What do type II diabetics know about cardiovascular risk factors? Relationship with the level of control of these factors].
    Navarro Oliver AF; Martínez Navarro A; Martínez Navarro MA; Leal Hernández M
    Semergen; 2014 Sep; 40(6):352-3. PubMed ID: 25016943
    [No Abstract]   [Full Text] [Related]  

  • 2. [Integral control of cardiovascular risk factors in type 2 diabetes in the Pallars Jussà and Sobirà regions (area of influence of the regional hospital of Pallars-Lleida)].
    Porres LD; Solans MR; Oña MF; Morilla L; Isarn RM; Milian ES; Pujol LE
    Rev Clin Esp; 2010; 210(7):332-7. PubMed ID: 20510408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
    Chan GC; Ghazali O; Khoo EM
    Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors that influence the cardiovascular morbidity in patients with type II diabetes mellitus.
    Kyriazis I; Mendrinos D; Saridi M
    Eur J Intern Med; 2010 Apr; 21(2):e9. PubMed ID: 20206869
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the knowledge, attitudes, and practices (KAP) of the women referred to health centers for cardiovascular disease (CVDs) and their risk factors.
    Mazloomy SS; Baghianimoghadam MH; Ehrampoush MH; Baghianimoghadam B; Mazidi M; Mozayan MR
    Health Care Women Int; 2014 Jan; 35(1):50-9. PubMed ID: 23638684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Davis TM
    Intern Med J; 2010 Apr; 40(4):286-92. PubMed ID: 19323700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and psychometric testing of the Health Beliefs Related to Cardiovascular Disease Scale: preliminary findings.
    Tovar EG; Rayens MK; Clark M; Nguyen H
    J Adv Nurs; 2010 Dec; 66(12):2772-84. PubMed ID: 20831570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome among diabetics and pre-diabetics of Jenu Kuruba tribe in Mysore district (JKDHS-2)--An evidence of metabolic abnormalities leading to increase in CVD's among Jenu Kuruba tribal population.
    Hathur B; Basavegowda M; Kulkarni P; Ashok NC
    Diabetes Metab Syndr; 2015; 9(4):205-9. PubMed ID: 26359305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sex and gender differences in cardiovascular prevention].
    Tschaftary A; Oertelt-Prigione S
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2541-5. PubMed ID: 25423468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey.
    Kabakcı G; Aydın M; Demir I; Kırma C; Özerkan F
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):313-20. PubMed ID: 21200100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CoLaus: diabetes and dyslipidemia, there is always something new!].
    Vollenweider P; Vaucher J; Bastardot F; Schmid R; Vidal PM; Waeber G
    Rev Med Suisse; 2011 Nov; 7(315):2122, 2124-6. PubMed ID: 22187780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating hypertension to reduce cardiovascular risk: a Korean perspective.
    Kim KI; Kim CH
    Clin Ther; 2012 Jul; 34(7):1559-68. PubMed ID: 22704810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do we adequately prescribe antiplatelet treatment to type 2 diabetic patients?].
    Gallego Arenas A; Novella Arribas B; Sierra García B; Ruiz Díaz L; Rodríguez Salvanés F;
    Semergen; 2012 Sep; 38(6):360-5. PubMed ID: 22935832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quantification of cardiovascular risk factors in subjects with/without diabetes mellitus.
    Pănuş C; Răducanu CL; Mota M
    Rom J Intern Med; 2004; 42(2):355-70. PubMed ID: 15529626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in cigarette smoking among Spanish diabetic adults, 1987-2009.
    Lopez-de-Andres A; Jiménez-García R; Hernández-Barrera V; Gil-de-Miguel A; Jiménez-Trujillo MI; Carrasco-Garrido P
    Diabetes Res Clin Pract; 2012 Oct; 98(1):e1-3. PubMed ID: 22770999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CRP and micro-albumin: new markers of cardiovascular risk in type 2 diabetes].
    El Oudi M; Aouni Z; Ouertani H; Mazigh C; Nsiri B; Zidi B; Machghoul S
    Ann Cardiol Angeiol (Paris); 2011 Aug; 60(4):207-10. PubMed ID: 21571249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the quality of care for elderly people with type 2 diabetes: the need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys).
    Pornet C; Bourdel-Marchasson I; Lecomte P; Eschwège E; Romon I; Fosse S; Assogba F; Roudier C; Fagot-Campagna A;
    Diabetes Metab; 2011 Apr; 37(2):152-61. PubMed ID: 21435929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intensive cardiovascular risk management in young people with type 2 diabetes.
    Song SH; Gray TA
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e70-2. PubMed ID: 21420751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What to make of ACCORD. Surprising new results from the landmark diabetes study.
    Johns Hopkins Med Lett Health After 50; 2010 Sep; 22(7):1-2, 7. PubMed ID: 20848750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.